Streetbeat News

Regulatory

BLK

Bitcoin reaches $30,000 level, prompting reactivation of two Satoshi-era wallets containing 100 BTC worth over $3 million. This coincides with BlackRock filing for a Bitcoin ETF, which could provide more accessible investment opportunities for institutional and individual investors.

Portfolio Pulse from Mehab Qureshi

June 27, 2023 | 11:59 am

FXI

GXC

Chinese Premier Li Qiang announced that China is on track to achieve its annual growth target of around 5%, despite some economic data missing analysts' expectations. Investors interested in China's economic performance might consider ETFs like the iShares China Large-Cap ETF (NYSE:FXI) or the SPDR S&P China ETF (NYSE:GXC).

Portfolio Pulse from Michael Cohen

June 27, 2023 | 11:57 am

GSK

The FDA has granted Fast Track designation to GSK plc's investigational vaccine for Neisseria gonorrhea, which is currently in an ongoing Phase 2 trial. Gonorrhea is the second most prevalent bacterial sexually transmitted infection worldwide, with an estimated 82 million new cases yearly. There are no approved vaccines for gonorrhea, and antimicrobial resistance to existing treatments is increasing.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 11:35 am

HARP

Harpoon Therapeutics has completed planned patient enrollment in its Phase 1 study of HPN217 for relapsed/refractory multiple myeloma.

Portfolio Pulse from Bill Haddad

June 27, 2023 | 11:35 am

ARWR

Arrowhead Pharmaceuticals has filed for regulatory clearance to initiate a Phase 1 clinical trial of ARO-SOD1, an RNAi-based investigational medicine for treating amyotrophic lateral sclerosis (ALS) caused by SOD1 mutations. ARO-SOD1 is the first therapeutic candidate leveraging Arrowhead's TRiM platform for CNS delivery.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 11:35 am

ANVS

Annovis Bio, a clinical stage drug platform company, has announced the creation of a novel crystalline form of buntanetap (ANVS402) and filed a new composition of matter provisional patent with the U.S. Patent and Trademark Office.

Portfolio Pulse from Bill Haddad

June 27, 2023 | 11:32 am

BLK

BTCUSD

ARK Investment Management claims to be the first in line for approval of a spot-Bitcoin ETF, ahead of BlackRock. Other asset managers such as Invesco, WisdomTree, and Valkyrie have also filed applications for their own Bitcoin funds.

Portfolio Pulse from Mehab Qureshi

June 27, 2023 | 11:22 am

ACIU

AC Immune's stock is trading higher after the FDA granted fast track designation for its anti-amyloid-beta active immunotherapy, ACI-24.060, for Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 11:16 am

FWBI

First Wave BioPharma has announced the publication of two patent applications for the composition of matter and methods of use claims governing its enhanced enteric microgranule delivery formulation of Adrulipase.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 11:11 am

BIIB

Alcyone Therapeutics announced a collaboration with Biogen for a pivotal FDA-approved trial of Alcyone's ThecaFlex DRx System to assess repeat intrathecal access, cerebrospinal fluid aspiration, and delivery of Spinraza (Nusinersen).

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 11:09 am